JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 15 November 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01515-06v1
81/3/1220    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tangudu, C.
Right arrow Articles by Gallagher, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tangudu, C.
Right arrow Articles by Gallagher, T.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01515-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

SARS Coronavirus Protein 6 Accelerates Murine Coronavirus Infections

Chandra Tangudu, Heidi Olivares, Jason Netland, Stanley Perlman, and Thomas Gallagher*

Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, IL; Interdisciplinary Program in Immunology and Department of Microbiology, University of Iowa, Iowa City, IA

* To whom correspondence should be addressed. Email: tgallag{at}lumc.edu.


   Abstract

One or more of the unique 3'-proximal open reading frames (ORFs) of the SARS coronavirus may encode determinants of virus virulence. A prime candidate is ORF6, which encodes a 63-amino acid membrane-associated peptide that can dramatically increase the lethality of an otherwise attenuated JHM strain of murine coronavirus (Pewe et al., 2005, J. Virol., 79:11335). To discern virulence mechanisms, we compared the in vitro growth properties of rJ.6, a recombinant JHM expressing the SARS peptide, with isogenic rJ.6-KO, which has an inactive ORF containing a mutated initiation codon and a termination codon at internal position 27. The rJ.6 infections proceeded rapidly, secreting progeny about 1.5 h earlier than rJ.6-KO. The rJ.6 infections were also set apart by early viral protein accumulation and by robust expansion via syncytia, a characteristic feature of JHM virus dissemination. We found no evidence for protein 6 operating at virus entry or assembly stages, as virions from either infection were indistinguishable. Rather, protein 6 appeared to operate by fostering viral RNA and protein synthesis, as RNA quantifications by RT-qPCR revealed viral RNA levels in the rJ.6 cultures that were 5 to 8 times higher than those lacking protein 6. Furthermore, protein 6 co-immunoprecipitated with viral RNAs and co-localized on cytoplasmic vesicles with replicating viral RNAs. The SARS coronavirus encodes a novel membrane protein 6 that can accelerate replication of a related mouse virus, a property that may explain its ability to increase in vivo virus virulence.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.